Identification of the predominant glycosaminoglycan-attachment site in soluble recombinant human thrombomodulin: potential regulation of functionality by glycosyltransferase competition for serine474 - PubMed (original) (raw)
Comparative Study
. 1993 Oct 1;295 ( Pt 1)(Pt 1):131-40.
doi: 10.1042/bj2950131.
Affiliations
- PMID: 8216207
- PMCID: PMC1134829
- DOI: 10.1042/bj2950131
Comparative Study
Identification of the predominant glycosaminoglycan-attachment site in soluble recombinant human thrombomodulin: potential regulation of functionality by glycosyltransferase competition for serine474
B Gerlitz et al. Biochem J. 1993.
Abstract
Thrombomodulin (TM) is an endothelial cell thrombin receptor that converts thrombin from a procoagulant to an anticoagulant enzyme. It has previously been shown that TM is expressed in both a high-M(r) form containing chondroitin sulphate and a low-M(r) form lacking this modification. Site-directed mutagenesis of a soluble human TM derivative (TMD1) was employed to determine the attachment site(s) of this functionally important oligosaccharide on the core protein. Although there are four serine residues within the Ser/Thr-rich domain of TMD1 that might support glycosaminoglycan assembly, our analysis demonstrates that the primary site of attachment is at Ser474, and evidence is presented for low levels of attachment at Ser472. It was possible to improve the overall degree of attachment by mutating Ser472 to glutamic acid (so as to conform Ser474 to the xylosyltransferase acceptor consensus acidic-Gly-Ser-Gly-acidic); however, a significant proportion (approx. 35%) of the total TM still lacked a glycosaminoglycan moiety. Mutants that possess a substitution for Ser474 show an increased mobility of their low-M(r) form on SDS/PAGE compared with native TMD1. Isolation and sequencing of a C-terminal peptide demonstrated that this serine is modified in the low-M(r) form of native TMD1. An apparent 'acceptor consensus overlap' at Ser474 suggests that the mechanism behind the glycosaminoglycan split of TM may involve a competition for substrate between xylosyltransferase and N-acetylgalactosaminyltransferase.
Similar articles
- Recombinant human thrombomodulin. Regulation of cofactor activity and anticoagulant function by a glycosaminoglycan side chain.
Parkinson JF, Vlahos CJ, Yan SC, Bang NU. Parkinson JF, et al. Biochem J. 1992 Apr 1;283 ( Pt 1)(Pt 1):151-7. doi: 10.1042/bj2830151. Biochem J. 1992. PMID: 1314561 Free PMC article. - Amino acid sequence surrounding the chondroitin sulfate attachment site of thrombomodulin regulates chondroitin polymerization.
Izumikawa T, Kitagawa H. Izumikawa T, et al. Biochem Biophys Res Commun. 2015 May 1;460(2):233-7. doi: 10.1016/j.bbrc.2015.03.016. Epub 2015 Mar 12. Biochem Biophys Res Commun. 2015. PMID: 25772620 - Modulation of glycosaminoglycan addition in naturally expressed and recombinant human thrombomodulin.
Lin JH, McLean K, Morser J, Young TA, Wydro RM, Andrews WH, Light DR. Lin JH, et al. J Biol Chem. 1994 Oct 7;269(40):25021-30. J Biol Chem. 1994. PMID: 7929188 - Structure-function relationships of the thrombin-thrombomodulin interaction.
Sadler JE, Lentz SR, Sheehan JP, Tsiang M, Wu Q. Sadler JE, et al. Haemostasis. 1993 Mar;23 Suppl 1:183-93. doi: 10.1159/000216927. Haemostasis. 1993. PMID: 8388351 Review. - Influence of core protein sequence on glycosaminoglycan assembly.
Esko JD, Zhang L. Esko JD, et al. Curr Opin Struct Biol. 1996 Oct;6(5):663-70. doi: 10.1016/s0959-440x(96)80034-0. Curr Opin Struct Biol. 1996. PMID: 8913690 Review.
Cited by
- Circulating Thrombomodulin: Release Mechanisms, Measurements, and Levels in Diseases and Medical Procedures.
Boron M, Hauzer-Martin T, Keil J, Sun XL. Boron M, et al. TH Open. 2022 Jul 11;6(3):e194-e212. doi: 10.1055/a-1801-2055. eCollection 2022 Jul. TH Open. 2022. PMID: 36046203 Free PMC article. Review. - Galnt17 loss-of-function leads to developmental delay and abnormal coordination, activity, and social interactions with cerebellar vermis pathology.
Chen CY, Seward CH, Song Y, Inamdar M, Leddy AM, Zhang H, Yoo J, Kao WC, Pawlowski H, Stubbs LJ. Chen CY, et al. Dev Biol. 2022 Oct;490:155-171. doi: 10.1016/j.ydbio.2022.08.002. Epub 2022 Aug 21. Dev Biol. 2022. PMID: 36002036 Free PMC article. - Overexpression of Galnt3 in chondrocytes resulted in dwarfism due to the increase of mucin-type O-glycans and reduction of glycosaminoglycans.
Yoshida CA, Kawane T, Moriishi T, Purushothaman A, Miyazaki T, Komori H, Mori M, Qin X, Hashimoto A, Sugahara K, Yamana K, Takada K, Komori T. Yoshida CA, et al. J Biol Chem. 2014 Sep 19;289(38):26584-26596. doi: 10.1074/jbc.M114.555987. Epub 2014 Aug 8. J Biol Chem. 2014. PMID: 25107907 Free PMC article. - Human thrombomodulin knock-in mice reveal differential effects of human thrombomodulin on thrombosis and atherosclerosis.
Raife TJ, Dwyre DM, Stevens JW, Erger RA, Leo L, Wilson KM, Fernández JA, Wilder J, Kim HS, Griffin JH, Maeda N, Lentz SR. Raife TJ, et al. Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2509-17. doi: 10.1161/ATVBAHA.111.236828. Arterioscler Thromb Vasc Biol. 2011. PMID: 21885846 Free PMC article. - Thrombomodulin and its role in inflammation.
Conway EM. Conway EM. Semin Immunopathol. 2012 Jan;34(1):107-25. doi: 10.1007/s00281-011-0282-8. Epub 2011 Jul 31. Semin Immunopathol. 2012. PMID: 21805323 Review.
References
- J Biol Chem. 1990 Sep 15;265(26):15424-31 - PubMed
- Biochem Biophys Res Commun. 1990 Sep 14;171(2):729-37 - PubMed
- J Biol Chem. 1990 Nov 25;265(33):20156-9 - PubMed
- J Biol Chem. 1991 Jan 15;266(2):894-902 - PubMed
- Mol Endocrinol. 1990 Apr;4(4):531-42 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases